Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy
Autor: | Chenming Zou, Songwei Tan, Qing Tang, Wei Zhang, Xueqin Gao, Mingxing Yin |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
multidrug-resistant
Cancer therapy Pharmaceutical Science 02 engineering and technology Polyethylene glycol RM1-950 Review Review Article 010402 general chemistry 01 natural sciences Metastasis chemistry.chemical_compound Drug Delivery Systems Neoplasms medicine Animals Humans Vitamin E cancer drug delivery system Drug Carriers d-α-tocopheryl polyethylene glycol succinate (TPGS) Tumor therapy Correction General Medicine 021001 nanoscience & nanotechnology Biocompatible material medicine.disease nanomedicine 0104 chemical sciences chemistry Drug delivery Cancer research Nanomedicine Therapeutics. Pharmacology 0210 nano-technology Drug carrier Corrigendum |
Zdroj: | Drug Delivery article-version (VoR) Version of Record Drug Delivery, Vol 24, Iss 1, Pp 1831-1842 (2017) |
ISSN: | 1521-0464 1071-7544 |
Popis: | Cancer remains an obstacle to be surmounted by humans. As an FDA-approved biocompatible drug excipient, d-α-tocopheryl polyethylene glycol succinate (TPGS) has been widely applied in drug delivery system (DDS). Along with in-depth analyses of TPGS-based DDS, increasingly attractive results have revealed that TPGS is able to act not only as a simple drug carrier but also as an assistant molecule with various bio-functions to improve anticancer efficacy. In this review, recent advances in TPGS-based DDS are summarized. TPGS can inhibit P-glycoprotein, enhance drug absorption, induce mitochondrial-associated apoptosis or other apoptotic pathways, promote drug penetration and tumor accumulation, and even inhibit tumor metastasis. As a result, many formulations, by using original TPGS, TPGS-drug conjugates or TPGS copolymers, were prepared, and as expected, an enhanced therapeutic effect was achieved in different tumor models, especially in multidrug resistant and metastatic tumors. Although the mechanisms by which TPGS participates in such functions are not yet very clear, considering its effectiveness in tumor treatment, TPGS-based DDS appears to be one of the best candidates for future clinical applications. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |